CNS & Neurological Disorders - Drug Targets

(Formerly Current Drug Targets - CNS & Neurological Disorders)

Editor-in-Chief:

Stephen D. Skaper  
Department of Pharmaceutical and Pharmacological Sciences
University of Padua
Padua
Italy

Back

Abstract Ahead of Print

Serum tryptophan, tryptophan catabolites and brain-derived neurotrophic factor in subgroups of youngsters with autism spectrum disorders

Volume:17
Heidi Ormstad*, Vesna Bryn, Robert Verkerk, Ola H. Skjeldal, Bente Halvorsen, Ola Didrik Saugstad, Jorn Isaksen and Michael Maes

Amyotrophic Lateral Sclerosis and Oxidative Stress: a Double-Blind Therapeutic Trial After Curcumin Supplementation

Volume:17
Lucia Chico*, Elena Caldarazzo Ienco, Costanza Bisordi, Annalisa Lo Gerfo, Lucia Petrozzi, Antonio Petrucci, Michelangelo Mancuso and Gabriele Siciliano

Serum Interleukin Levels And Insulin Resistance In Major Depressive Disorder

Volume:17
Hussein Kadhem Al-Hakeim, Sadiq Neama Al-Kufi, Arafat Hussein Al-Dujaili and Michael Maes *

Therapeutic Advancement in Alzheimer Disease: New Hopes on the Horizon?

Volume:17
Ajeet Singh, Abshar Hasan, Sakshi Tiwari and Lalit M Pandey*

Oxidative stress: Major threat in traumatic brain injury

Volume:17
Nidhi Khatri, Manisha Thankur, Vikas Pareek, Sandeep Kumar, Sunil Sharma and Ashok Kumar Datusalia*

A novel combination of ω-3 fatty acids and nano-curcumin modulates interleukin-6 gene expression and high sensitivity C-reactive protein serum levels in patients with migraine: a randomized clinical trial study

Volume:17
Mina Abdolahi*, Payam Sarraf, Mohammad Hassan Javanbakht, Niyaz Mohammadzadeh Honarvar, Mahsa Hatami, Neda Soveyd, Abbas Tafakhori, Mohsen Sedighiyan, Mona Djalali, Arash Jafarieh, Yousef Masoudian and Mahmoud Djalali